The Alzheimer's Association is proud to celebrate the individuals who have made significant contributions to further the vision of a world without Alzheimer's disease.
On This Page:
The Alzheimer’s Association International Conference® (AAIC®) provides the Alzheimer's Association with the opportunity to present awards to some of the most prominent leaders in the field. These prestigious awards recognize the work of distinguished Alzheimer's researchers, as well as those who are just beginning their career in this vital field.
The AAIC Lifetime Achievement Awards recognize a senior investigator whose contributions, whether they have been in research, leadership or mentorship, have shown a lasting impact on the field and whose body of work has demonstrated a career-long commitment towards progress against Alzheimer's and dementia.
The awards are named in honor of Henry Wisniewski, M.D., Ph.D.; Khalid Iqbal, Ph.D.; and Bengt Winblad, M.D., Ph.D. — co-founders of the Alzheimer's Association scientific conference, now known as AAIC. Since its inception and first iteration they each held key leadership roles in planning and conceptualizing the conference:
The Blas Frangione Early Career Achievement Award recognizes early career researchers whose cutting edge research in Alzheimer’s and dementia has the potential to impact the field by propelling it in novel directions. It also recognizes a researcher’s demonstrated personal and professional qualities that show promise for a productive and impactful scientific career in the Alzheimer’s and dementia field.
The Blas Frangione Award was established by and named for Blas Frangione, M.D., Ph.D., who is Professor Emeritus of Pathology and Psychiatry and Research Professor in the Departments of Pathology and Neurology at NYU Langone Medical Center. The Blas Frangione Foundation supports research in neuroscience.
Named in honor of noted scientist, administrator, consultant, lecturer and author, Zaven Khachaturian, Ph.D., this award recognizes an individual whose compelling vision, selfless dedication, and extraordinary achievement has significantly advanced the field of Alzheimer science. Dr. Khachaturian currently is editor-in-chief of Alzheimer’s & Dementia: The Journal of the Alzheimer's Association. He is universally recognized as the chief architect of Alzheimer's research in the United States. Prior to leaving federal service, he served as the Director of the Office of Alzheimer’s Disease Research and coordinated all Alzheimer’s disease-related activities at the National Institutes of Health (NIH).
There will not be a call for nominations for this award.
The award honors William (Bill) Thies who passed away on August 16, 2020. During his tenure from 1998 to 2020, as the Alzheimer's Association's chief medical and scientific officer, and then later as its senior medical science advisor, he was instrumental in bringing AAIC under the umbrella of Association activities, played a key role in launching the peer-reviewed journal Alzheimer's & Dementia®: The Journal of the Alzheimer's Association, as well as the Association's Research Roundtable. During his tenure, the Association’s research grant budget more than doubled.
In addition, Thies was committed to the creation of a professional society that gathered health care professionals and researchers focused on Alzheimer's and all dementias. That society, created in 2008, was ISTAART. Dr. Randy Nixon, an ISTAART member himself, says, "A further legacy of Bill's is the ISTAART program currently linking thousands of Alzheimer's researchers. Its success owes much to Bill's leadership."
The Inge Grundke-Iqbal Award for Alzheimer's Research is presented to the senior author of the most impactful study published in Alzheimer's research over the preceding two years (Jan. 1, 2020 – Dec. 31, 2021).
Only members from the International Society to Advance Alzheimer’s Research and Treatment (ISTAART) may nominate candidates.
Inge Grundke-Iqbal served as Professor and Head of Neuroimmunology at the New York State Institute for Basic Research in Developmental Disabilities from 1977 until her passing in September 2012. She was a world-renowned neuroscientist and Alzheimer disease researcher. She was the author/co-author of over 250 scientific publications in prestigious American and international journals and books. Dr. Grundke-Iqbal made several seminal discoveries in the biology of Alzheimer's disease and related conditions. Her discovery of the abnormal hyperphosphorylation of tau opened a whole new area of research in neurodegeneration, especially Alzheimer's disease and related tauopathies. Her research contributions won her several U.S. Public Health Service, National Institutes of Health and non-federal research grants and honors. Dr. Grundke-Iqbal served as a member of the International Scientific Advisory Committee of the International Conference on Alzheimer's Disease and Related Disorders (now known as the Alzheimer's Association International Conference).